Publications by authors named "Louis Chaykin"

Claim this Profile
I
Impact of baseline characteristics and beta-cell function on the efficacy and safety of subcutaneous once-weekly semaglutide: A patient-level, pooled analysis of the SUSTAIN 1-5 trials.
Vanita R Aroda, Matthew S Capehorn, Louis Chaykin, Juan P Frias, Nanna L Lausvig

Diabetes Obes Metab· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes from a randomized, crossover trial comparing a pen injector with insulin degludec versus a pen injector with insulin glargine U100 in patients with type 2 diabetes.
Mark L Warren, Meryl Brod, Jonas Håkan-Bloch, Thomas Sparre, Louis B Chaykin

Curr Med Res Opin· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Insulin Degludec Versus Insulin Glargine U100 on Hypoglycemia in Hispanic Patients With Type 2 Diabetes: Results From the SWITCH 2 Trial.
Louis Chaykin, Anuj Bhargava, Raymond de la Rosa, Carol H Wysham, Lone Nørgård Troelsen

Clin Diabetes· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: Pooled analysis of the SUSTAIN 1-5 trials.
Mark Warren, Louis Chaykin, David Trachtenbarg, Gurudutt Nayak, Nelun Wijayasinghe

Diabetes Obes Metab· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.
Carol Wysham, Anuj Bhargava, Louis Chaykin, Raymond de la Rosa, Yehuda Handelsman

JAMA· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin.
Mark L Warren, Louis B Chaykin, Serge Jabbour, Mae Sheikh-Ali, Charlotte T Hansen

Clin Diabetes· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensification of IDegAsp Twice Daily (Adding Insulin Aspart vs. Switching To Basal-Bolus): Exploratory Randomized Trial in Type 2 Diabetes.
Wan Mohamaed Wan Bebakar, Louis Chaykin, Malene Lundgren Hersløv, Søren Rasmussen

Diabetes Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial.
Sultan Linjawi, Bruce W Bode, Louis B Chaykin, Jean-Pierre Courrèges, Yehuda Handelsman

Diabetes Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TREATMENT INTENSIFICATION WITH INSULIN DEGLUDEC/INSULIN ASPART TWICE DAILY: RANDOMIZED STUDY TO COMPARE SIMPLE AND STEP-WISE TITRATION ALGORITHMS.
Gregg Gerety, Wan Mohamad Wan Bebakar, Louis Chaykin, Mesut Ozkaya, Stanislava Macura

Endocr Pract· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Insulin Degludec 200 U/mL and Insulin Degludec 100 U/mL in Patients with Type 2 Diabetes (Begin: Compare).
Bruce W Bode, Louis B Chaykin, Allen M Sussman, Mark L Warren, Marcus Niemeyer

Endocr Pract· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes.
Philip Raskin, Titus Gylvin, Wayne Weng, Louis Chaykin

Diabetes Metab Res Rev· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis